Jasmin Richardson
Physician Assistant · Arlington, VANPI 1053567354
Payments from drug & device makers
Across 459 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$1K
- GSK$772
- Pfizer$504
- Merck$490
- Novo Nordisk$449
- plus $3K from 40 others
What the payments were for
- Food & beverage$8,576100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,576 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 36 | $51,165 |
| FarxigaDapagliflozin Propanediol | 42 | $43,439 |
| JardianceEmpagliflozin | 56 | $36,357 |
| EliquisApixaban | 33 | $32,063 |
| MounjaroTirzepatide | 20 | $28,623 |
| Tresiba Flextouch U-200Insulin Degludec | 30 | $27,410 |
| TrulicityDulaglutide | 21 | $20,535 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $20,205 |
| JanuviaSitagliptin Phosphate | 18 | $19,414 |
| RybelsusSemaglutide | 14 | $14,858 |
| GemtesaVibegron | 14 | $7,726 |
| LinzessLinaclotide | 11 | $7,626 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,159 |
| Atorvastatin Calcium | 228 | $2,619 |
| Rosuvastatin Calcium | 118 | $2,198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $449 | $66,02350 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,011 | $50,59954 claims |
| Lilly USA, LLCMounjaro, Trulicity | $325 | $49,15841 claims |
| Boehringer IngelheimJardiance | $133 | $36,35756 claims |
| PfizerEliquis | $504 | $32,06333 claims |
| GSKTrelegy Ellipta | $772 | $20,20530 claims |
| MerckJanuvia | $490 | $19,41418 claims |
| AbbVieLinzess, Synthroid | $1,929 | $8,38429 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $141 | $7,72614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Arlington
- Jameka McElroy-BrooklynArlington$65K
- Victoria TaillacArlington$26K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Hillary HartungNorfolk$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.